Press Releases

Date	Title	Company
22-Sep-2023	THOUSANDS WITH INCURABLE CANCER TO GET FIVE YEARS’ REMISSION THANKS TO PIONEERING TREATMENT	Myeloma UK
22-Sep-2023	NHS and Government take steps to boost Organ donation registrations	NHS Blood and Transplant
22-Sep-2023	ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs	The Institute of Cancer Research, London
22-Sep-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
22-Sep-2023	National Institute for Health and Care Excellence gives green light to Darzalex® (daratumumab) with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma	Janssen UK
22-Sep-2023	Arthroscopy Visualization Systems Market US$ 902.5 Million by 2032, at a CAGR of 7.1%: Driven by Increasing Prevalence of Musculoskeletal Disorders \| FMI	MARKITWIRED
22-Sep-2023	NICE RECOMMENDS LILLY’S MIRIKIZUMAB (OMVOH ®▼) FOR THE TREATMENT OF ELIGIBLE ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS	Eli Lilly & Co.
22-Sep-2023	Breast Biopsy Devices Market On a Trajectory to Reach US$ 3.6 Billion by 2032, Growing at a Steady CAGR of 5.5% \| FMI	MARKITWIRED
22-Sep-2023	Arriello appoints experienced biotech expert, Kate Coleman, as VP of Quality & Compliance	Arriello
22-Sep-2023	Creative Enzymes Unveils Custom Blends Product Line for Bioprocessing Solutions	Creative Enzymes
22-Sep-2023	TME Pharma Announces Selection of Two Clinical Abstracts on the Ongoing NOX-A12 GLORIA Phase 1/2 Trial in Glioblastoma for Presentation at ESMO 2023 Congress and SNO 2023 Annual Meeting	Businesswire
22-Sep-2023	Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary General Meeting on October 10, 2023	Businesswire
22-Sep-2023	AffyImmune Therapeutics Named 2023 Scrip Award Finalist for Best Oncology R&D Advance	AffyImmune Therapeutics
22-Sep-2023	Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance	Sunshine Biopharma
22-Sep-2023	Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial	AstraZeneca
22-Sep-2023	Proteomics Market, Which is at the Intersection of Genomics and Functionality, Is Poised to Grow at a CAGR Of 13.5% by 2032, According To FMI	MARKITWIRED
22-Sep-2023	Physical Therapy Supplies Market to Reach US$ 23,621.17 Million by 2032, Boosted By Demand for Therapeutic Recovery Supplies \| FMI	MARKITWIRED
22-Sep-2023	Global Surgical Sutures Market to Reach US$ 13.9 Billion by 2032, Driven by Technological Innovations and Growing Geriatric Population \| FMI	MARKITWIRED
22-Sep-2023	Electric Handpieces Market is likely to US$ 803.8 Million by 2032 Gain Popularity Due to Benefits Such as Reduced Fatigue and Improved Efficiency \| FMI	MARKITWIRED
22-Sep-2023	Emerging Countries Such as China and India Witnessing Rapid Growth in Outsourced Testing Services Market is projected to reach US$ 76.3 billion by 2032\| FMI	MARKITWIRED